1.
Breccia M, Alimena G. SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs. MJHID [Internet]. 2Jan.2014 [cited 11Dec.2019];6(1):e2014003. Available from: http://www.mjhid.org/index.php/mjhid/article/view/2014.003